Circulating Microvesicle-Associated Inducible Nitric Oxide Synthase Is a Novel Therapeutic Target to Treat Sepsis: Current Status and Future Considerations

To determine whether mitigating the harmful effects of circulating microvesicle-associated inducible nitric oxide (MV-A iNOS) in vivo increases the survival of challenged mice in three different mouse models of sepsis, the ability of anti-MV-A iNOS monoclonal antibodies (mAbs) to rescue challenged m...

Descripción completa

Detalles Bibliográficos
Autores principales: Webber, Robert J., Sweet, Richard M., Webber, Douglas S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705916/
https://www.ncbi.nlm.nih.gov/pubmed/34948167
http://dx.doi.org/10.3390/ijms222413371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705916/
https://www.ncbi.nlm.nih.gov/pubmed/34948167
http://dx.doi.org/10.3390/ijms222413371

Ejemplares similares